Mayne Pharma Group Stock Price Prediction
| MAYNF Stock | USD 2.01 0.07 3.37% |
Momentum 37
Sell Extended
Oversold | Overbought |
Using Mayne Pharma hype-based prediction, you can estimate the value of Mayne Pharma Group from the perspective of Mayne Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Mayne Pharma to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Mayne because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Mayne Pharma after-hype prediction price | USD 2.01 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Mayne |
Mayne Pharma After-Hype Price Density Analysis
As far as predicting the price of Mayne Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Mayne Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Mayne Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Mayne Pharma Estimiated After-Hype Price Volatility
In the context of predicting Mayne Pharma's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Mayne Pharma's historical news coverage. Mayne Pharma's after-hype downside and upside margins for the prediction period are 0.10 and 9.25, respectively. We have considered Mayne Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Mayne Pharma is dangerous at this time. Analysis and calculation of next after-hype price of Mayne Pharma Group is based on 3 months time horizon.
Mayne Pharma Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Mayne Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Mayne Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Mayne Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.85 | 7.24 | 0.00 | 0.57 | 0 Events / Month | 3 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
2.01 | 2.01 | 0.00 |
|
Mayne Pharma Hype Timeline
Mayne Pharma Group is now traded for 2.01. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.57. Mayne is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is now at -0.85%. %. The volatility of related hype on Mayne Pharma is about 1083.83%, with the expected price after the next announcement by competition of 2.58. About 23.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.73. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Mayne Pharma Group recorded a loss per share of 0.03. The entity last dividend was issued on the 18th of January 2023. The firm had 987:937 split on the 30th of June 2016. Assuming the 90 days horizon the next estimated press release will be uncertain. Check out Mayne Pharma Basic Forecasting Models to cross-verify your projections.Mayne Pharma Related Hype Analysis
Having access to credible news sources related to Mayne Pharma's direct competition is more important than ever and may enhance your ability to predict Mayne Pharma's future price movements. Getting to know how Mayne Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Mayne Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BHCCF | Benchmark Holdings plc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SLNCF | Silence Therapeutics plc | 0.00 | 0 per month | 0.00 | (0.02) | 12.50 | (11.11) | 58.78 | |
| TRGNF | Transgene SA | 0.03 | 8 per month | 0.00 | 0.09 | 0.00 | 0.00 | 61.69 | |
| HNSBF | Hansa Biopharma AB | 0.00 | 0 per month | 0.00 | (0.14) | 0.00 | 0.00 | 36.46 | |
| CPHRF | Cipher Pharmaceuticals | 0.00 | 0 per month | 1.97 | (0.01) | 3.83 | (2.33) | 11.28 | |
| AONC | American Oncology Network | 0.00 | 5 per month | 8.41 | 0.08 | 13.97 | (15.38) | 143.49 | |
| EVGRF | China Evergrande New | 0.00 | 2 per month | 0.00 | 0.13 | 0.00 | 0.00 | 39.68 | |
| ORPEF | Orpea SA | 0.00 | 16 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BHHKF | Benchmark Botanics | 0.04 | 13 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| TSNLF | Tristel PLC | 6.61 | 2 per month | 0.00 | 0.03 | 0.00 | 0.00 | 4.96 |
Mayne Pharma Additional Predictive Modules
Most predictive techniques to examine Mayne price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Mayne using various technical indicators. When you analyze Mayne charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Mayne Pharma Predictive Indicators
The successful prediction of Mayne Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Mayne Pharma Group, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Mayne Pharma based on analysis of Mayne Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Mayne Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Mayne Pharma's related companies.
Currently Active Assets on Macroaxis
Complementary Tools for Mayne Pink Sheet analysis
When running Mayne Pharma's price analysis, check to measure Mayne Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mayne Pharma is operating at the current time. Most of Mayne Pharma's value examination focuses on studying past and present price action to predict the probability of Mayne Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mayne Pharma's price. Additionally, you may evaluate how the addition of Mayne Pharma to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |